Join the India Equity Telegram Group for analysis, updates and results

AUROPHARMA has declared results for the period ended Sep 2021.

Quarterly Results

[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

• Sales for period ended Sep 2021 is Rs 5942.0 cr compared to Rs 6483.0 cr for period ended Sep 2020, a fall of 8.3%
• Operating Profits reported at Rs 1176.0 cr for period ended Sep 2021 vis-vis 1412.0 for period ended Sep 2020 .
• Operating Margins contracted -198.9 bps for period ended Sep 2021 vis-vis Sep 2020 .
• The EPS for Sep 2021 was Rs 11.9 compared to Rs 13.14 for previous quarter ended Jun 2021 and Rs 13.79 for Sep 2020
• The stock is trading at Rs 672 and a market cap of Rs 39375 cr

[/s2If]

Trading Chart

Further analysis and Full Company Research with investing scores is available here: AUROPHARMA

Join BharatEquity Telegram Channel for updated India results, analysis and News
Join Our Twitter